Bone replacement materials, method for producing a bone replacement material and medical kits for the treatment of bone defects
US-10751443-B2 · Aug 25, 2020 · US
US9913926B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9913926-B2 |
| Application number | US-201213617882-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 14, 2012 |
| Priority date | Jan 24, 2008 |
| Publication date | Mar 13, 2018 |
| Grant date | Mar 13, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Described herein is the synthesis of adhesive complex coacervates and their use thereof. The adhesive complex coacervates are composed of a mixture of one or more polycations and one or more polyanions. The polycations and polyanions in the adhesive complex coacervate are crosslinked with one another by covalent bonds upon curing. The adhesive complex coacervates have several desirable features when compared to conventional bioadhesives, which are effective in water-based applications. The adhesive complex coacervates described herein exhibit good interfacial tension in water when applied to a substrate (i.e., they spread over the interface rather than being beaded up). Additionally, the ability of the complex coacervate to crosslink intermolecularly increases the cohesive strength of the adhesive complex coacervate. They have numerous biological applications as bioadhesives and drug delivery devices and are particularly useful in underwater applications and situations where water is present such as, for example, physiological conditions.
Opening claim text (preview).
What is claimed: 1. An adhesive comprising a fluid complex coacervate, wherein the complex coacervate comprises a polyamino compound and a polyphosphate compound, wherein each polyamino compound and polyphosphate compound includes at least one fragment having the formula VII wherein R 1 , R 2 , and R 3 are, independently, hydrogen or an alkyl group, X is oxygen or NR 5 , where R 5 is hydrogen or an alkyl group, and m is from 1 to 10, or the pharmaceutically-acceptable salt thereof, wherein at least one of R 2 or R 3 is an acrylate group or a methacrylate group, wherein the acrylate group or methacrylate group on the polyamino compound and polyphosphate compound are capable of covalently crosslinking with one another, and wherein the complex coacervate does not include a multivalent cation. 2. The coacervate of claim 1 , wherein the polyphosphate compound comprises a polymer comprising at least one fragment comprising the formula II wherein R 4 is hydrogen or an alkyl group, and n is from 1 to 10, or the pharmaceutically-acceptable salt thereof. 3. The coacervate of claim 1 , wherein the polyphosphate compound comprises at least one dihydroxyl aromatic group capable of undergoing oxidation, wherein the dihydroxyl aromatic group is covalently attached to the polyphosphate compound. 4. The coacervate of claim 1 , wherein the coacervate further comprises one or more bioactive agents encapsulated in the complex. 5. The coacervate of claim 1 , wherein the coacervate further comprises a stabilized oxidant complex. 6. An adhesive produced by the process comprising (a) heating an adhesive complex coacervate of claim 1 , wherein upon heating the adhesive complex coacervate the coacervate is converted to an insoluble solid; and (b) covalently crosslinking the polyphosphate compound and polyamino compound in the insoluble solid to produce the adhesive. 7. An adhesive produced by the process comprising (a) preparing an adhesive complex coacervate of claim 1 ; (b) adjusting the pH of the adhesive complex coacervate to produce an insoluble solid; and (c) covalently crosslinking the polyamino compound and polyphosphate compound in the insoluble solid to produce the adhesive. 8. A method for repairing a bone fracture in a subject, comprising contacting the fractured bone with the adhesive complex coacervate of claim 1 . 9. A method for adhering a metal substrate to a bone of a subject comprising contacting the bone with the adhesive complex coacervate of claim 1 and applying the metal substrate to the coated bone. 10. A method for adhering a bone-tissue scaffold to a bone of a subject comprising contacting the bone and tissue with the adhesive complex coacervate of claim 1 and applying the bone-tissue scaffold to the bone and tissue. 11. A method for delivering one or more bioactive agents comprising administering the adhesive complex coacervate of claim 1 to a subject. 12. A method for repairing a corneal laceration in a subject, comprising applying to the laceration the adhesive complex coacervate of claim 1 . 13. A method for inhibiting blood flow in a blood vessel of a subject comprising introducing the adhesive complex coacervate of claim 1 into the vessel. 14. The coacervate of claim 1 , wherein the coacervate has a pH greater than or equal to 7.0. 15. The coacervate of claim 1 , wherein the coacervate has a pH from 7. 0 to 9.0. 16. The coacervate of claim 1 , wherein R 2 is hydrogen and R 3 is an acrylate or methacrylate group. 17. The coacervate of claim 1 , wherein R 1 is methyl, R 2 is hydrogen, R 3 is an acrylate or methacrylate group, X is NH, and m is 2. 18. The coacervate of claim 1 , wherein the polyamino compound has at least one fragment of the formula I wherein R 1 , R 2 , and R 3 are, independently, hydrogen or an alkyl group, X is oxygen or NR 5 , where R 5 is hydrogen or an alkyl group, and m is from 1 to 10, or the pharmaceutically-acceptable salt thereof.
for bone diseases, e.g. rachitism, Paget's disease · CPC title
Oxidation · CPC title
leading to a crosslinking, either explicitly or inherently · CPC title
Mixtures of macromolecular compounds · CPC title
Type of release, e.g. controlled, sustained, slow · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.